Summary:
- Apple has been ordered to pay $634 million in a patent dispute with medical technology company Masimo over the heart rate monitoring technology used in the Apple Watch.
- The jury found that Apple infringed on two of Masimo's patents related to pulse oximetry, a technology that measures the oxygen levels in a person's blood.
- This ruling is a significant setback for Apple, as the company has heavily promoted the health and fitness tracking capabilities of the Apple Watch as a key selling point.